| 产品名称 |
9,12,20-Trioxo-8,19-bis(phenylmethoxy)-2,8,13,19-tetraazatricosanedioic Acid 1-(1,1-Dimethylethyl)-d4 Ester from UNITED STATES BIOLOGICAL |
| 产品详情 |
| Edit |   |
| Product Name | 9,12,20-Trioxo-8,19-bis(phenylmethoxy)-2,8,13,19-tetraazatricosanedioic Acid 1-(1,1-Dimethylethyl)-d4 Ester |
| Description | 9,12,20-Trioxo-8,19-bis(phenylmethoxy)-2,8,13,19-tetraazatricosanedioic Acid 1-(1,1-Dimethylethyl) Ester is an intermediate in synthesizing Deferoxamine-d7 TFA Salt (D228982), a labelled Deferoxamine Mesylate (D228980), which is an iron chelating agent used in therapy for patients with sickle cell diseases and iron overload. Studies suggest that it can exert potential antioxidant neuroprotective effects in stroke patients. Molecular Formula: C37H50D4N4O9 Solubility: Dichloromethane Molecular Weight: 702.87 |
| Size | 1mg, 2.5mg |
| Concentration | n/a |
| Applications | n/a |
| Other Names | n/a |
| Gene, Accession, CAS # | n/a |
| Catalog # | 440522 |
| Price | |
| Order / More Info | 9,12,20-Trioxo-8,19-bis(phenylmethoxy)-2,8,13,19-tetraazatricosanedioic Acid 1-(1,1-Dimethylethyl)-d4 Ester from UNITED STATES BIOLOGICAL |
| Product Specific References | n/a |
| 产品资料 |
|
|